Fig. 1From: Long-term safety and effectiveness of a continuous erythropoietin receptor activator (CERA) in patients with renal anemia: a prospective, observational, multicenter studyPatient disposition. HD, hemodialysis; ND, not on dialysis; PD, peritoneal dialysisBack to article page